Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Lennon David James
CHIEF EXECUTIVE OFFICER at Whitehawk Therapeutics. Filing since 3 Oct 2024.
CIK 0001995275
Company
Date
Role
Action
Shares
Amount
Of holding
WHWK
Whitehawk Therapeutics, Inc.
9 Apr 2026
CHIEF EXECUTIVE OFFICER
Sold at will
14,500
$49.01K
2.7%
WHWK
Whitehawk Therapeutics, Inc.
8 Apr 2026
CHIEF EXECUTIVE OFFICER
Sold at will
63,945
$217.41K
10.7%
WHWK
Whitehawk Therapeutics, Inc.
7 Apr 2026
CHIEF EXECUTIVE OFFICER
Sold at will
94,087
$322.72K
13.6%
WHWK
Whitehawk Therapeutics, Inc.
6 Apr 2026
CHIEF EXECUTIVE OFFICER
Sold at will
102,395
$359.41K
12.9%
WHWK
Whitehawk Therapeutics, Inc.
2 Apr 2026
CHIEF EXECUTIVE OFFICER
Sold at will
26,858
$93.47K
3.3%
WHWK
Whitehawk Therapeutics, Inc.
2 Mar 2026
CHIEF EXECUTIVE OFFICER
Sold at will
5,100
$16.88K
10.3%
WHWK
Whitehawk Therapeutics, Inc.
3 Mar 2025
CHIEF EXECUTIVE OFFICER
Sold at will
5,690
$13.37K
14.5%
WHWK
Whitehawk Therapeutics, Inc.
3 Oct 2024
CHIEF EXECUTIVE OFFICER
Sold at will
9,689
$18.80K
29.8%
8 decisions on file.
